Roald Ekanger

922 total citations
19 papers, 758 citations indexed

About

Roald Ekanger is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Roald Ekanger has authored 19 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Roald Ekanger's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Cancer Treatment and Pharmacology (3 papers) and Pancreatic function and diabetes (3 papers). Roald Ekanger is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Cancer Treatment and Pharmacology (3 papers) and Pancreatic function and diabetes (3 papers). Roald Ekanger collaborates with scholars based in Norway, United States and Sweden. Roald Ekanger's co-authors include Stein Ove Døskeland, Robert H. Suva, Jon P. Miller, Dagfinn Øgreid, Priscilla A. Sturm, Jackie D. Corbin, Arne Kolstad, Thoralf Christoffersen, Tor‐Erik Sand and Olav Karsten Vintermyr and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Roald Ekanger

18 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roald Ekanger Norway	12	353	175	119	72	71	19	758
Mária Magócsi Hungary	18	351 1.0×	182 1.0×	30 0.3×	94 1.3×	81 1.1×	25	715
Christopher Yea United Kingdom	13	316 0.9×	58 0.3×	68 0.6×	49 0.7×	83 1.2×	28	692
Valeria Muzio Italy	15	191 0.5×	174 1.0×	87 0.7×	86 1.2×	30 0.4×	22	660
Olcay Batuman United States	14	346 1.0×	149 0.9×	38 0.3×	54 0.8×	40 0.6×	34	792
C R Scriver Canada	18	485 1.4×	132 0.8×	33 0.3×	153 2.1×	29 0.4×	37	1.1k
Giancarlo Avanzi Italy	10	205 0.6×	83 0.5×	68 0.6×	56 0.8×	32 0.5×	16	582
Minghua Yu China	18	353 1.0×	109 0.6×	56 0.5×	54 0.8×	40 0.6×	47	811
Brendan C. Lanpher United States	17	581 1.6×	74 0.4×	59 0.5×	109 1.5×	57 0.8×	41	1.2k
Patrick P. Koty United States	15	416 1.2×	144 0.8×	69 0.6×	238 3.3×	20 0.3×	29	930
H Rivera United States	11	403 1.1×	68 0.4×	43 0.4×	48 0.7×	30 0.4×	21	664

Countries citing papers authored by Roald Ekanger

Since Specialization

Citations

This map shows the geographic impact of Roald Ekanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roald Ekanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roald Ekanger more than expected).

Fields of papers citing papers by Roald Ekanger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roald Ekanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roald Ekanger. The network helps show where Roald Ekanger may publish in the future.

Co-authorship network of co-authors of Roald Ekanger

This figure shows the co-authorship network connecting the top 25 collaborators of Roald Ekanger. A scholar is included among the top collaborators of Roald Ekanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roald Ekanger. Roald Ekanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Yri, Olav Erich, Dag Torfoss, Olav Hungnes, et al.. (2011). Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood. 118(26). 6769–6771. 119 indexed citations

Andersen, Niels Smedegaard, Lone Bredo Pedersen, Anna Laurell, et al.. (2009). Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma. Journal of Clinical Oncology. 27(26). 4365–4370. 92 indexed citations

Ekanger, Roald, Bjørn Hagen, A. Himmelmann, et al.. (2005). [Primary treatment of ovarian cancer].. PubMed. 125(3). 278–81. 5 indexed citations

Liseth, Knut, et al.. (2004). Overlevelse etter høydosebehandling med autolog stamcellestøtte. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

Liseth, Knut, et al.. (2004). [Survival after high-dose therapy with autologous stem cell support].. PubMed. 124(10). 1374–5. 2 indexed citations

Hervig, Tor, et al.. (2000). [High dose chemotherapy with autologous stem cell support in cancer patients].. PubMed. 120(13). 1523–8. 1 indexed citations

Ekanger, Roald, et al.. (1989). Comparison of the two classes of binding sites (A and B) of type I and type II cyclic‐AMP‐dependent protein kinases by using cyclic nucleotide analogs. European Journal of Biochemistry. 181(1). 19–31. 121 indexed citations

Ekanger, Roald, Olav Karsten Vintermyr, Gunnar Houge, et al.. (1989). The expression of cAMP-dependent protein kinase subunits is differentially regulated during liver regeneration. Journal of Biological Chemistry. 264(8). 4374–4382. 47 indexed citations

Ekanger, Roald, Olav Karsten Vintermyr, & Stein Ove Døskeland. (1988). The amounts of rat liver cyclic AMP-dependent protein kinase I and II are differentially regulated by diet. Biochemical Journal. 256(2). 447–452. 13 indexed citations

10.

Ekanger, Roald, et al.. (1988). [9] Use of antibody- sepharose columns to study hormonal activation of cAMP-dependent protein kinase isozymes. Methods in enzymology on CD-ROM/Methods in enzymology. 159. 97–104. 10 indexed citations

11.

Øgreid, Dagfinn, Yoon S. Cho‐Chung, Roald Ekanger, et al.. (1987). Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomas.. PubMed. 47(10). 2576–82. 5 indexed citations

12.

Fukami, Miriam H., et al.. (1986). Relation between induction of ornithine decarboxylase and specific gene expression in rat liver in response to the tumor promoter agent clofibrate. Carcinogenesis. 7(9). 1441–1446. 13 indexed citations

13.

Ekanger, Roald, et al.. (1985). Characterization of cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozymes in normal and neoplastic fetal rat brain cells.. PubMed. 45(6). 2578–83. 8 indexed citations

14.

Øgreid, Dagfinn, Roald Ekanger, Robert H. Suva, et al.. (1985). Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. European Journal of Biochemistry. 150(1). 219–227. 104 indexed citations

15.

Ekanger, Roald, Tor‐Erik Sand, Dagfinn Øgreid, Thoralf Christoffersen, & Stein Ove Døskeland. (1985). The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes.. Journal of Biological Chemistry. 260(6). 3393–3401. 41 indexed citations

16.

Ekanger, Roald, et al.. (1983). Mapping of the two intrachain cyclic nucleotide binding sites of adenosine cyclic 3',5'-phosphate dependent protein kinase I. Biochemistry. 22(5). 1094–1101. 55 indexed citations

17.

Kvinnsland, Stener, Roald Ekanger, Stein Ove Døskeland, & Thor Thorsen. (1983). Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Research and Treatment. 3(1). 67–72. 13 indexed citations

18.

Lindemann, Rolf, et al.. (1978). Hematological changes in normal men during prolonged severe exercise.. PubMed. 32(4). 107–11. 42 indexed citations

19.

Ekanger, Roald, et al.. (1978). Performance, mood, and clinical symptoms in men exposed to prolonged, severe physical work and sleep deprivation.. PubMed. 49(9). 1065–73. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact